Home Markets Regeneron to defend against DOJ complaint on drug-price manipulation

Regeneron to defend against DOJ complaint on drug-price manipulation

Apr 16, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/regeneron-to-defend-us-justice-departments-complaint-on-drugpricing-manipulation-3379239

You May Also Like

NYSE short interest rose 2.4 percent in mid-December

Japan’s comedian-turned-investor launches fund with ex-Goldman ‘stock geek’

Exclusive-KKR, Bain bids ranged from $4.8 billion to $7.6 billion for Seven & i assets, sources say

Colombia stocks lower at close of trade; COLCAP down 0.39%

Mexico stocks lower at close of trade; S&P/BMV IPC down 0.27%

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.91%